127 related articles for article (PubMed ID: 20435660)
1. Long-term survival and risk factors for recurrence in stage I non-small cell lung cancer patients with tumors up to 3 cm in maximum dimension.
Maeda R; Yoshida J; Ishii G; Hishida T; Aokage K; Nishimura M; Nishiwaki Y; Nagai K
Chest; 2010 Aug; 138(2):357-62. PubMed ID: 20435660
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification.
Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
Chest; 2011 Dec; 140(6):1494-1502. PubMed ID: 21622548
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of microscopic vessel invasion and visceral pleural invasion in non-small cell lung cancer: a retrospective analysis of 2657 patients.
Neri S; Yoshida J; Ishii G; Matsumura Y; Aokage K; Hishida T; Nagai K
Ann Surg; 2014 Aug; 260(2):383-8. PubMed ID: 24646539
[TBL] [Abstract][Full Text] [Related]
4. Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.
Shimada Y; Saji H; Yoshida K; Kakihana M; Honda H; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
J Thorac Oncol; 2012 Aug; 7(8):1263-70. PubMed ID: 22673056
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
[TBL] [Abstract][Full Text] [Related]
6. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer.
Dziedzic DA; Rudzinski P; Langfort R; Orlowski T;
Clin Lung Cancer; 2016 Sep; 17(5):e157-e167. PubMed ID: 26831834
[TBL] [Abstract][Full Text] [Related]
8. Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion.
Moon Y; Lee KY; Park JK
World J Surg; 2017 Nov; 41(11):2769-2777. PubMed ID: 28597091
[TBL] [Abstract][Full Text] [Related]
9. The Frequency and Prognostic Impact of Pathological Microscopic Vascular Invasion According to Tumor Size in Non-Small Cell Lung Cancer.
Shimada Y; Saji H; Kato Y; Kudo Y; Maeda J; Yoshida K; Hagiwara M; Matsubayashi J; Kakihana M; Kajiwara N; Ohira T; Ikeda N
Chest; 2016 Mar; 149(3):775-85. PubMed ID: 26379115
[TBL] [Abstract][Full Text] [Related]
10. Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size.
David E; Thall PF; Kalhor N; Hofstetter WL; Rice DC; Roth JA; Swisher SG; Walsh GL; Vaporciyan AA; Wei C; Mehran RJ
Ann Thorac Surg; 2013 Jun; 95(6):1872-7; discussion 1877. PubMed ID: 23643547
[TBL] [Abstract][Full Text] [Related]
11. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.
Harpole DH; Herndon JE; Young WG; Wolfe WG; Sabiston DC
Cancer; 1995 Sep; 76(5):787-96. PubMed ID: 8625181
[TBL] [Abstract][Full Text] [Related]
12. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
[TBL] [Abstract][Full Text] [Related]
13. Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer.
Wang S; Zhang B; Qian J; Qiao R; Xu J; Zhang L; Zhao Y; Zhang Y; Wang R; Zhao R; Han B
Lung Cancer; 2018 Nov; 125():245-252. PubMed ID: 30429028
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
[TBL] [Abstract][Full Text] [Related]
15. Effect of visceral pleural invasion on the prognosis of patients with lymph node negative non-small cell lung cancer.
Tian D; Pei Y; Zheng Q; Zhang J; Li S; Wang X; Lin D; Yang Y
Thorac Cancer; 2017 Mar; 8(2):97-105. PubMed ID: 28256095
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of visceral pleural involvement in early-stage lung cancer.
Lakha S; Gomez JE; Flores RM; Wisnivesky JP
Chest; 2014 Dec; 146(6):1619-1626. PubMed ID: 25032521
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma.
Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
Eur J Cardiothorac Surg; 2013 Sep; 44(3):e200-6. PubMed ID: 23766428
[TBL] [Abstract][Full Text] [Related]
18. Impact of visceral pleural invasion on the survival of patients with non-small cell lung cancer.
Kudo Y; Saji H; Shimada Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Lung Cancer; 2012 Nov; 78(2):153-60. PubMed ID: 22944144
[TBL] [Abstract][Full Text] [Related]
19. [Multivariate survival analysis of patients with stage I NSCLC].
Pei J; Han B; Zhang J; Gu A
Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):926-32. PubMed ID: 22152692
[TBL] [Abstract][Full Text] [Related]
20. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
